source
- SonoThera raises $125M for non-viral gene therapy approachSonoThera has secured $125 million to take its ultrasound-based gene therapy technology into the clinic. The company is focused on two lead programs in Duchenne muscular dystrophy and autosomal dom…Endpoints · 1mo ago↗ source
- Parabilis sets a record with a $670M biotech IPOThe largest-ever new stock sale for a venture-backed biotech company extends a streak of large IPOs in 2026 that’s now resulted in 12 drug startups securing more than $4.1 billion combined.BioPharma Dive · 1mo ago↗ source
- Shattuck raises $75M; Servier inks neuro ASO pact with n-Lorem FoundationShattuck Labs initiates $75M public offering: The US biotech {$STTK} is selling over 10.5 million shares for $4 apiece, and issuing pre-funded warrants for certain investors. The offering is set to…